SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-23-003175
Accepted
2023-11-03 00:16:00
Documents
1
Effectiveness Date
2023-11-02
Registration Form
S-1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 594
  Complete submission text file 9999999995-23-003175.txt   1731
Mailing Address 430 E. 29TH STREET FLOOR 14 NEW YORK NY 10016
Business Address 430 E. 29TH STREET FLOOR 14 NEW YORK NY 10016 (212) 547-9879
Lexeo Therapeutics, Inc. (Filer) CIK: 0001907108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-274777 | Film No.: 231374363
SIC: 2836 Biological Products, (No Diagnostic Substances)